Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Xeris Biopharma Holdings, Inc.

XERS · Nasdaq · CIK 0001867096 · Healthcare · Drug Manufacturers—Specialty & Generic

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

29 Form 4 transaction lines observed in the same window
20 sales · 9 option, withholding, award, gift or other lines

Last qualifying purchase2025-06-13 · McCulloch Kevin · $109.5K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Hecht BethSee Remarks
▼▼▼▼▼▼
McCulloch KevinSee Remarks
▼○▼▼▼▼
Pieper StevenSee Remarks
▼▼▼▼▼
PERSKY MARLADirector
▼○
JOHNSON JOHNDirector
○▼
HALKUFF DAWNDirector
○▼
● Purchase▼ Sale○ Other

Showing the six most active owners; 5 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-06-13 · McCulloch Kevin.

Recent Form 4 activity

0Purchases
32Sales
36Other Form 4 lines
42SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING20 sale line(s) · context only
OTHER9 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
7,202,379
Previous report
8,058,977
Avg daily volume
4,146,096
Days to cover
1.7

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-06-13McCulloch KevinPurchase (P)Common Stock25,000USD 4.38USD 109,500SEC filing ↗
2024-08-12Schmid John P.Purchase (P)Common Stock4,515USD 2.25USD 10,159SEC filing ↗
2024-08-09Schmid John P.Purchase (P)Common Stock4,285USD 2.37USD 10,155SEC filing ↗
2024-05-10Schmid John P.Purchase (P)Common Stock5,400USD 1.91USD 10,314SEC filing ↗
2024-03-14Schmid John P.Purchase (P)Common Stock4,500USD 2.16USD 9,720SEC filing ↗
2023-11-27SHERMAN JEFFREY WPurchase (P)Common Stock5,400USD 1.87USD 10,098SEC filing ↗
2023-11-20Pieper StevenPurchase (P)Common Stock28,000USD 1.95USD 54,600SEC filing ↗
2023-11-20HALKUFF DAWNPurchase (P)Common Stock5,410USD 1.84USD 9,954SEC filing ↗
2023-11-17Shannon John Patrick JrPurchase (P)Common Stock30,769USD 1.64USD 50,461SEC filing ↗
2023-11-16Schmid John P.Purchase (P)Common Stock6,500USD 1.51USD 9,815SEC filing ↗
2023-11-14PERSKY MARLAPurchase (P)Common Stock6,370USD 1.58USD 10,065SEC filing ↗
2023-08-09Edick Paul RPurchase (P)Common Stock10,000USD 2.38USD 23,800SEC filing ↗
2022-12-13Edick Paul RPurchase (P)Common Stock20,000USD 1.45USD 29,000SEC filing ↗
2022-05-12Edick Paul RPurchase (P)Common Stock100,000USD 1.40USD 140,000SEC filing ↗
2021-11-15Edick Paul RPurchase (P)Common Stock20,000USD 2.28USD 45,600SEC filing ↗

Form 4 evidence

68 transaction lines in the latest 365-day window; 226 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-01Pieper StevenSale (S)Common Stock5,000USD 9.41USD 47,036SEC filing ↗
2026-10-01McCulloch KevinSale (S)Common Stock15,000USD 9.41USD 141,120SEC filing ↗
2026-10-01Hecht BethSale (S)Common Stock16,666USD 9.41USD 156,792SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-01Pieper StevenSale (S)Common Stock5,000USD 9.41USD 47,036SEC filing ↗
2026-10-01McCulloch KevinSale (S)Common Stock15,000USD 9.41USD 141,120SEC filing ↗
2026-10-01Hecht BethSale (S)Common Stock16,666USD 9.41USD 156,792SEC filing ↗
2026-09-28McCulloch KevinSale (S)Common Stock25,000USD 10.00USD 250,000SEC filing ↗
2026-09-01Pieper StevenSale (S)Common Stock5,000USD 8.50USD 42,500SEC filing ↗
2026-09-01McCulloch KevinSale (S)Common Stock15,000USD 8.49USD 127,350SEC filing ↗
2026-09-01Hecht BethSale (S)Common Stock16,666USD 8.49USD 141,494SEC filing ↗
2026-08-12Pieper StevenSale (S)Common Stock5,000USD 8.50USD 42,500SEC filing ↗
2026-08-03McCulloch KevinSale (S)Common Stock15,000USD 8.02USD 120,300SEC filing ↗
2026-08-03Hecht BethSale (S)Common Stock16,666USD 8.01USD 133,495SEC filing ↗
2026-08-01Shannon John Patrick JrTax withholding (F)Common Stock36,645USD 8.08USD 296,092SEC filing ↗
2026-08-01McCulloch KevinTax withholding (F)Common Stock21,918USD 8.08USD 177,097SEC filing ↗
2026-07-07Pieper StevenSale (S)Common Stock27,600USD 8.52USD 235,152SEC filing ↗
2026-07-06Pieper StevenSale (S)Common Stock17,400USD 8.50USD 147,900SEC filing ↗
2026-07-01McCulloch KevinSale (S)Common Stock90,000USD 8.03USD 722,700SEC filing ↗
2026-07-01KREHER NERISSAAward / grant (A)Common Stock33,582USD 0.00USD 0SEC filing ↗
2026-07-01Hecht BethSale (S)Common Stock16,666USD 8.03USD 133,828SEC filing ↗
2026-06-04PERSKY MARLAAward / grant (A)Common Stock24,193USD 0.00USD 0SEC filing ↗
2026-06-04Kong GarhengAward / grant (A)Common Stock24,193USD 0.00USD 0SEC filing ↗
2026-06-04JOHNSON JOHNSale (S)Common Stock15,000USD 6.09USD 91,350SEC filing ↗
2026-06-04JOHNSON JOHNAward / grant (A)Common Stock24,193USD 0.00USD 0SEC filing ↗
2026-06-04HALKUFF DAWNSale (S)Common Stock20,000USD 6.09USD 121,800SEC filing ↗
2026-06-04HALKUFF DAWNAward / grant (A)Common Stock24,193USD 0.00USD 0SEC filing ↗
2026-06-04Brady James AloysiusAward / grant (A)Common Stock24,193USD 0.00USD 0SEC filing ↗
2026-06-04BORMANN-KENNEDY BARBARA-JEAN ANNESale (S)Common Stock16,000USD 6.09USD 97,440SEC filing ↗
2026-06-04BORMANN-KENNEDY BARBARA-JEAN ANNEAward / grant (A)Common Stock24,193USD 0.00USD 0SEC filing ↗
2026-06-03PERSKY MARLASale (S)Common Stock15,500USD 5.90USD 91,450SEC filing ↗
2026-06-01Hecht BethSale (S)Common Stock16,667USD 6.06USD 101,002SEC filing ↗
2026-05-01Hecht BethSale (S)Common Stock16,667USD 6.23USD 103,835SEC filing ↗
2026-04-01Hecht BethSale (S)Common Stock16,667USD 5.99USD 99,835SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerXERS
CIK0001867096
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history226 transaction lines from 2021-10-05 to 2026-10-01
19 P purchase lines · 38 S sale lines · 169 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.